Search

  • HOME
  • Search
Original Article
1574
Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
Na Young Lee, Min Jea Shin, Gi Soo Youn, Sang Jun Yoon, Ye Rin Choi, Hyeong Seop Kim, Haripriya Gupta, Sang Hak Han, Byoung Kook Kim, Do Yup Lee, Tae Sik Park, Hotaik Sung, Byung Yong Kim, Ki Tae Suk
Clin Mol Hepatol. 2021;27(1):110-124.   Published online December 3, 2020
View: 9605   Download: 457  Web of Science: 57  Crossref: 62
Editorial
1588
Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try
Tian-Yi Ren, Xiao-Yan Li, Jian-Gao Fan
Clin Mol Hepatol. 2021;27(1):83-86.   Published online December 3, 2020
View: 4689   Download: 157  Web of Science: 1  Crossref: 1
Review
Microbiota, a key player in alcoholic liver disease
Anne-Marie Cassard, Dragos Ciocan
Clin Mol Hepatol. 2018;24(2):100-107.   Published online December 22, 2017
View: 11638   Download: 519  Web of Science: 59  Crossref: 60
1 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 731
TOTAL : 1809242
Close layer